CRL · Charles River Laboratories International, Inc.
Market Cap
$13.93B
Shares
47.74M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-27 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-02 | 2026-06-30 | |
| 8-K | 2026-05-11 | 2026-05-05 | |
| 10-Q | 2026-05-07 | 2026-03-28 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-03-31 | 2026-05-05 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-02-18 | — | |
| 10-K | 2026-02-18 | 2025-12-27 | |
| 8-K | 2026-02-18 | — | |
| 8-K | 2026-01-13 | — | |
| 8-K | 2026-01-09 | 2026-01-08 | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-11-17 | 2025-11-14 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-27 | |
| 8-K/A | 2025-09-19 | 2025-09-12 | |
| 8-K | 2025-09-16 | 2025-09-12 | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-28 | |
| 8-K | 2025-05-23 | 2025-05-20 | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-29 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-02 | 2025-05-20 | |
| 8-K | 2025-02-21 | 2025-02-20 | |
| 8-K | 2025-02-19 | — | |
| 10-K | 2025-02-19 | 2024-12-28 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2024-12-13 | — | |
| 10-Q | 2024-11-06 | 2024-09-28 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-29 | |
| 8-K | 2024-05-10 | 2024-05-08 | |
| 10-Q | 2024-05-09 | 2024-03-30 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-03-29 | 2024-05-08 | |
| 10-K | 2024-02-14 | 2023-12-30 | |
| 8-K | 2024-02-14 | — | |
| 8-K | 2024-01-24 | 2024-01-22 | |
| 8-K | 2024-01-16 | 2024-01-09 | |
| 8-K | 2023-11-15 | 2023-11-14 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 10-Q | 2023-08-09 | 2023-07-01 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-05-15 | — |
Showing 1–50 of 102 filings
Key facts
CIK
1100682
CUSIP
159864107
13F (30d)
398 filings
391 filers
Visit website
Investor relations